Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Photocure will present its first quarter report on Tuesday 23 May 2017 at Hotel Continental, Oslo, Norway. Additionally, Dr. Daneshmand will present the new phase 3 study results with Blue Light...
-
21.5% of patients with recurrence of bladder cancer would have been missed if BLFC with Cysview had not been used in the surveillance setting, which is highly significant (p<0.0001) ...
-
Oslo, Norway, May 12th, 2017: Photocure ASA (Photocure, PHO:OSE), today announced that a Phase 3 trial investigating Blue Light Flexible Cystoscopy (BLFC(TM)) with Cysview®/Hexvix® in the...
-
Oslo, Norway, May 5 2017: Photocure ASA (OSE:PHO), today announced the appointment of Jeremy Bahr as Chief Business Officer. "I am pleased to welcome Jeremy to the Photocure team, strengthening our...
-
Dr. Jan Hendrik Egberts - Board ChairmanDr. Johanna HolldackMs. Gwen Melincoff Oslo, Norway April, 28, 2017: Photocure ASA (OSE:PHO), a specialty pharmaceutical company and world leader in...
-
Oslo, 27 April 2017: Photocure ASA (OSE: PHO), held its annual general meeting on 27 April 2017 at 17:00 hours (CET). All proposals were resolved as presented in the notice convening the general...
-
Data on US Registry Study for BLC(TM) with Cysview/Hexvix will also be Presented at AUA Oslo, Norway, April 26, 2017: Photocure ASA (Photocure, PHO:OSE), today announced that results from the BLFC...
-
Oslo, 24 April 2017: Photocure ASA (OSE: PHO). Bente-Lill Bjerkelund Romøren has as chairperson of the board of directors of PHO received proxies to vote for 1,389,360 shares at the annual general...
-
Oslo, 24 April 2017: Photocure ASA (OSE: PHO). Hans Peter Bøhn has received proxies to vote for 1,545,735 shares at the annual general meeting of PHO on 27 April 2017 (the "AGM"), representing...
-
On 6 April 2017 Kjetil Hestdal, President and CEO of Photocure ASA, purchased 5 000 Photocure shares at a price of NOK 28.00 each. Kjetil Hestdal now holds 133 873 shares and 92 500 options in...